Alessandro Siccardi - Medacta Group Supply Director
| MOVE Stock | 110.60 0.20 0.18% |
Insider
Alessandro Siccardi is Supply Director of Medacta Group SA
| Age | 37 |
| Phone | 41 91 696 60 60 |
| Web | https://www.medacta.com |
Medacta Group Management Efficiency
The company has return on total asset (ROA) of 0.0752 % which means that it generated a profit of $0.0752 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2135 %, meaning that it generated $0.2135 on every $100 dollars invested by stockholders. Medacta Group's management efficiency ratios could be used to measure how well Medacta Group manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Fabian Hildbrand | Medartis Holding AG | N/A | |
| Patrick Christ | Medartis Holding AG | 53 | |
| Michael Suter | Bachem Holding AG | N/A | |
| Mareike Loch | Medartis Holding AG | 53 | |
| Ludger Althoff | Sonova H Ag | 59 | |
| Thomas Fruh | Bachem Holding AG | 66 | |
| Thomas Bernhardsgrutter | Sonova H Ag | N/A | |
| Roland Schrmann | Bachem Holding AG | 59 | |
| Fabian Chiozza | VAT Group AG | 42 | |
| Robert Woolley | Sonova H Ag | 47 | |
| Michael Staroverov | Bachem Holding AG | N/A | |
| Manuel Schaer | Medartis Holding AG | 53 | |
| Thomas Meier | Bachem Holding AG | 55 | |
| K Dahlstroem | VAT Group AG | N/A | |
| JeanMarc Fellay | Bachem Holding AG | N/A | |
| Martin Grieder | Sonova H Ag | 58 | |
| Wolfgang Becker | Straumann Holding AG | 57 | |
| Christophe Fond | Sonova H Ag | 57 | |
| U Gantner | VAT Group AG | N/A | |
| Aurelio Sahagun | Straumann Holding AG | 50 | |
| O Mller | VAT Group AG | N/A | |
Management Performance
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 |
Medacta Group SA Leadership Team
Elected by the shareholders, the Medacta Group's board of directors comprises two types of representatives: Medacta Group inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Medacta. The board's role is to monitor Medacta Group's management team and ensure that shareholders' interests are well served. Medacta Group's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Medacta Group's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Alessandro Siccardi, Supply Director | ||
| Donato Cortesi, S Board | ||
| Gianluca Olgiati, Director Marketing | ||
| Alberto Siccardi, Founder Chairman | ||
| Francesco Siccardi, Chief Officer | ||
| Asif Hussain, HR Director | ||
| Corrado Farsetta, Chief Officer |
Medacta Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Medacta Group a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.21 | |||
| Return On Asset | 0.0752 | |||
| Profit Margin | 0.12 % | |||
| Operating Margin | 0.15 % | |||
| Current Valuation | 1.98 B | |||
| Shares Outstanding | 19.98 M | |||
| Shares Owned By Insiders | 69.53 % | |||
| Shares Owned By Institutions | 17.99 % | |||
| Price To Book | 7.98 X | |||
| Price To Sales | 4.85 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Medacta Stock Analysis
When running Medacta Group's price analysis, check to measure Medacta Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medacta Group is operating at the current time. Most of Medacta Group's value examination focuses on studying past and present price action to predict the probability of Medacta Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medacta Group's price. Additionally, you may evaluate how the addition of Medacta Group to your portfolios can decrease your overall portfolio volatility.